IL200020A0
Dosage regimen for comt inhibitors
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
46 members in 24 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 07002091 | European Patent Office (EPO) | A | |
| 2007000043 | Portugal | W |
Members46
| Document | Office | Kind | |
|---|---|---|---|
| AU2007346018A1 | Australia | A1 | |
| CA2678391A1 | Canada | A1 | |
| WO2008094053A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AR065098A1 | Argentina | A1 | |
| MX2009008051A | Mexico | A | |
| KR20090104859A | Republic of Korea | A | |
| NO20092905L | Norway | L | |
| EP2124947A1 | European Patent Office (EPO) | A1 | |
| CN101631548A | China | A | |
| IL200020A0This record | Israel | A0 | |
| IL200020D0 | Israel | D0 | |
| US2010113529A1 | United States of America | A1 | |
| ZA200905940B | South Africa | B | |
| JP2011500506A | Japan | A | |
| RU2009132188A | Russian Federation | A | |
| AU2007346018A2 | Australia | A2 | |
| EP2481410A1 | European Patent Office (EPO) | A1 | |
| US8524746B2 | United States of America | B2 | |
| US2013331416A1 | United States of America | A1 | |
| BRPI0721213A2 | Brazil | A2 | |
| RU2518483C2 | Russian Federation | C2 | |
| JP5517629B2 | Japan | B2 | |
| CN101631548B | China | B | |
| KR101522157B1 | Republic of Korea | B1 | |
| US2016009699A1 | United States of America | A1 | |
| EP2481410B1 | European Patent Office (EPO) | B1 | |
| IL200020A | Israel | A | |
| PT2481410T | Portugal | T | |
| DK2481410T3 | Denmark | T3 | |
| LT2481410T | Lithuania | T | |
| HRP20161261T1 | Croatia | T1 | |
| HRP20161261T8 | Croatia | T8 | |
| CA2678391C | Canada | C | |
| ES2597705T3 | Spain | T3 | |
| SI2481410T1 | Slovenia | T1 | |
| PL2481410T3 | Poland | T3 | |
| CY1118311T1 | Cyprus | T1 | |
| EP2124947B1 | European Patent Office (EPO) | B1 | |
| HUE031317T2 | Hungary | T2 | |
| US9745290B2 | United States of America | B2 | |
| PT2124947T | Portugal | T | |
| DK2124947T3 | Denmark | T3 | |
| ES2644049T3 | Spain | T3 | |
| AR109590A2 | Argentina | A2 | |
| BRPI0721213B1 | Brazil | B1 | |
| KR101522157B9 | Republic of Korea | B9 |
5 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Application
- 200020
Titles
- English
- DOSAGE REGIMEN FOR COMT INHIBITORS
Classification
- CPC, 12
- C07D413/04
- A61K31/4427
- A61K31/4439
- A61K31/198
- A61P25/00
- A61P25/02
- A61P25/14
- A61P25/16
- A61P25/18
- A61P43/00
- A61K45/06
- A61K9/20